237 related articles for article (PubMed ID: 24195605)
41. Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease.
Dunbar CE
Annu Rev Med; 1996; 47():11-20. PubMed ID: 8712765
[TBL] [Abstract][Full Text] [Related]
42. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
Roth JA; Nguyen D; Lawrence DD; Kemp BL; Carrasco CH; Ferson DZ; Hong WK; Komaki R; Lee JJ; Nesbitt JC; Pisters KM; Putnam JB; Schea R; Shin DM; Walsh GL; Dolormente MM; Han CI; Martin FD; Yen N; Xu K; Stephens LC; McDonnell TJ; Mukhopadhyay T; Cai D
Nat Med; 1996 Sep; 2(9):985-91. PubMed ID: 8782455
[TBL] [Abstract][Full Text] [Related]
43. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.
Lauret E; Riviere I; Rousseau V; Vieillard V; De Maeyer-Guignard J; De Maeyer E
Hum Gene Ther; 1993 Oct; 4(5):567-77. PubMed ID: 8280795
[TBL] [Abstract][Full Text] [Related]
44. Environmental risk assessment of replication competent viral vectors applied in clinical trials: potential effects of inserted sequences.
van den Akker E; van der Vlugt CJ; Bleijs DA; Bergmans HE
Curr Gene Ther; 2013 Dec; 13(6):395-412. PubMed ID: 24397527
[TBL] [Abstract][Full Text] [Related]
45. Curing genetic disease with gene therapy.
Williams DA
Trans Am Clin Climatol Assoc; 2014; 125():122-8; discussion 128-9. PubMed ID: 25125725
[TBL] [Abstract][Full Text] [Related]
46. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis.
Knight S; Collins M; Takeuchi Y
Curr Gene Ther; 2013 Jun; 13(3):211-27. PubMed ID: 23590635
[TBL] [Abstract][Full Text] [Related]
47. Pseudotyped retroviral vectors for studies of human gene therapy.
Friedmann T; Yee JK
Nat Med; 1995 Mar; 1(3):275-7. PubMed ID: 7585046
[No Abstract] [Full Text] [Related]
48. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
[TBL] [Abstract][Full Text] [Related]
49. Virus vector design in gene therapy.
Günzburg WH; Salmons B
Mol Med Today; 1995 Dec; 1(9):410-7. PubMed ID: 9415189
[TBL] [Abstract][Full Text] [Related]
50. Integration Site Analysis in Gene Therapy Patients: Expectations and Reality.
Biasco L
Hum Gene Ther; 2017 Dec; 28(12):1122-1129. PubMed ID: 29160103
[TBL] [Abstract][Full Text] [Related]
51. Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.
Dalba C; Bellier B; Kasahara N; Klatzmann D
Mol Ther; 2007 Mar; 15(3):457-66. PubMed ID: 17245356
[TBL] [Abstract][Full Text] [Related]
52. Genetic marking and manipulation of hematopoietic progenitor cells using retroviral vectors.
Brenner MK
Immunomethods; 1994 Dec; 5(3):204-10. PubMed ID: 7780687
[TBL] [Abstract][Full Text] [Related]
53. Transfer of genes to humans: early lessons and obstacles to success.
Crystal RG
Science; 1995 Oct; 270(5235):404-10. PubMed ID: 7569994
[TBL] [Abstract][Full Text] [Related]
54. Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells.
Long Z; Li LP; Grooms T; Lockey C; Nader K; Mychkovsky I; Mueller S; Burimski I; Ryan P; Kikuchi G; Ennist D; Marcus S; Otto E; McGarrity G
Hum Gene Ther; 1998 May; 9(8):1165-72. PubMed ID: 9625255
[TBL] [Abstract][Full Text] [Related]
55. [Progress in improvement of lentiviral vectors' transcriptional read-through].
He J; Zhang J
Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1541-8. PubMed ID: 22393708
[TBL] [Abstract][Full Text] [Related]
56. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
57. Retroviral integrations in gene therapy trials.
Biasco L; Baricordi C; Aiuti A
Mol Ther; 2012 Apr; 20(4):709-16. PubMed ID: 22252453
[TBL] [Abstract][Full Text] [Related]
58. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
Onodera M; Nelson DM; Sakiyama Y; Candotti F; Blaese RM
Acta Haematol; 1999; 101(2):89-96. PubMed ID: 10202239
[TBL] [Abstract][Full Text] [Related]
59. Retroviral vectors for cancer gene therapy.
Collins M
Ernst Schering Res Found Workshop; 2000; (30):99-104. PubMed ID: 10943318
[No Abstract] [Full Text] [Related]
60. Retroviral vectors. From laboratory tools to molecular medicine.
Vile RG; Tuszynski A; Castleden S
Mol Biotechnol; 1996 Apr; 5(2):139-58. PubMed ID: 8734426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
